Whole population secondary prevention of coronary heart disease in Scotland: the HEARTS database

Frank M Sullivan1, Peter T Donnan, Tom Love

  • 1Health Informatics Centre, University of Dundee, Scotland.

Insights

The HEARTS collaboration improves chronic disease management by linking patient data for better coronary heart disease (CHD) secondary prevention. This system shows a 5-10% improvement in patient outcomes and therapy prescribing compared to other regions.

Area of Science:

  • Health Services Research
  • Cardiovascular Disease Management
  • Health Informatics

Background:

  • Implementing evidence-based chronic disease management presents significant challenges.
  • Effective interventions for secondary prevention of coronary heart disease (CHD) require robust data systems.

Purpose of the Study:

  • To describe the HEARTS collaboration (Heart disease Evidence-based Audit and Research in Tayside Scotland) system.
  • To highlight the system's role as a strategic decision support tool for secondary CHD prevention.

Main Methods:

  • Linking national databases with manually validated electronic patient records from hospital and family practices.
  • Utilizing a facilitated educational process and the NHS intranet to provide feedback to practices.
  • Implementing a system covering all residents of the Tayside region, Scotland.

Main Results:

  • The system registered 9,828 patients with a history of myocardial infarction (MI) or revascularization procedures.
  • Observed improvements in clinical status and prescribing of effective therapies were 5-10% greater than in other Scottish regions.
  • Demonstrated successful integration of data for clinical decision support.

Conclusions:

  • The HEARTS collaboration system effectively supports secondary prevention of CHD.
  • Data-driven feedback and facilitated education enhance clinical practice and patient outcomes.
  • This model offers a scalable approach to improving chronic disease management through health informatics.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...